news on tirzepatide Peptide of the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Tirzepatide shows success in maintaining

A natural solution thats been hidden in plain sight this whole time

April 16, 2025: Attorneys in Ozempic Lawsuit Argue Over Diagnostic Criteria for Gastroparesis Attorneys in the multidistrict litigation against Ozempic and other GLP-1 manufacturers are disagreeing about what constitutes a gastroparesis diagnosis

Receptor Binding and Downstream Signaling IGF-1 LR3 binds IGF1R with affinity similar to native IGF-1, preserving the receptor-level pharmacology while altering the pharmacokinetics

But there are patients who say, Oh, that medication never worked for me. Well, did it not work for you because the product was less potent